Cancer Chemotherapy and Biotherapy Principles and Practice

Name: Cancer Chemotherapy and Biotherapy Principles and Practice
Price: 48.54 USD
Availability: InStock
ISBN: 9781605474311

ISBN-10: 1605474312

ISBN-13: 9781605474311

Edition: 5th 2011 (Revised)

Authors: Bruce A. Chabner, Dan L. Longo

List price: $179.00

30 day, 100% satisfaction guarantee!

Marketplace

1 new & used from $48.54

what's this?

Rush Rewards U
Members Receive:

You have reached 400 XP and carrot coins. That is the daily max!

Description:

Updated to include the newest drugs and those currently in development, Cancer Chemotherapy and Biotherapy, Fifth Edition is a comprehensive reference on the preclinical and clinical pharmacology of anticancer agents. Organized by drug class, the book provides the latest information on all drugs and biological agents--their mechanisms of action, interactions with other agents, toxicities, side effects, and mechanisms of resistance. Chapters emphasize pharmacology and mechanisms of action at the molecular and cellular levels, followed by clinical activity and toxicity, both acute and delayed. The authors explain the rationale for use of drugs in specific schedules and combinations and offer…

Book details

List price: $179.00
Edition: 5th
Copyright year: 2011
Publisher: Lippincott Williams & Wilkins
Publication date: 11/16/2010
Binding: Hardcover
Pages: 848
Size: 8.75" wide x 11.25" long x 1.50" tall
Weight: 4.884
Language: English

Dan L. Longo, MDScientific DirectorNational Institute on AgingNational Institutes of HealthBethesda, Maryland




Basic Principles Of Cancer Treatment



Clinical Strategies for Cancer Treatment: The Role of Drugs




Target Identification and Drug Discovery




Clinical Drug Development and Approval for Marketing




Principles of Pharmacokinetics




Special Aspects of Brain Tumor Chemotherapy




Pharmacogenetics




Barriers to Drug Delivery




Cytotoxic Agents



Antifolates




Fluoro-pyrimidines




Cytidine Analogues




Purine Analogues




Hydroxyurea




Antimitotic Drugs




Alkylating Agents (Including Methylating Agents)




Platinum Analogues




Antitumor Antibiotics (Including Bleomycin)




Topoisomerase I Inhibitors




Topoisomerase II Inhibitors: Anthracyclines




Topoisomerase II Inhibitors: Etoposide, Teniposide




L-Asparaginase




Molecularly Targeted Therapies



Proteosome Inhibitors




HDAC Inhibitors




Differentiating Agents (Retinoids)




Arsenic Trioxide




Monoclonal Antibodies: Discovery & Development




Anti-angiogenic Agents (Including MonAB)




Anti-EGFR Therapies (Including MonAB)




Anti-her 2 Therapies




Intracellular Signal Inhibitors (bcr-abl)




Signal Transduction Inhibitors in Development




Inhibitors of the PI3k Pathway & Mitotic Kinase




Immunologic Agents



Interferon and Cytokines




Vaccines




Adoptive Cellular Therapies




Immuno-modulatory Drugs (IMIDS, Anti-CTLA4)




Hormonal Therapy



Hormonal Therapy of Breast Cancer




GNRH Agonists and Anti-Androgens




Supportive Care



Pain Management in Cancer Patients




Colony Stimulating Factors




Anti-nausea Medications




Bone Loss Modulators




Intravenous Access and Catheter Management




Survivorship



Monitoring for Late Side Effects of Chemotherapy